Responsiveness of Infrapatellar Fat Pad Volume Change to Body Weight Loss or Gain: Data from the Osteoarthritis Initiative

2018 ◽  
Vol 205 (1) ◽  
pp. 53-62 ◽  
Author(s):  
Eva Steidle-Kloc ◽  
Torben Dannhauer ◽  
Wolfgang Wirth ◽  
Felix Eckstein
Keyword(s):  
Weight Loss ◽  
Body Weight ◽  
Volume Change ◽  
Weight Change ◽  
Subcutaneous Fat ◽  
Body Weight Loss ◽  
Infrapatellar Fat Pad ◽  
Cross Sectional ◽  
Potential Link ◽  
Osteoarthritis Initiative

Obesity is a potent risk factor for knee osteoarthritis (OA) that is driven by mechanical and potentially endocrine mechanisms, and it affects women more frequently than men. The infrapatellar fat pat (IPFP) represents a potential link between obesity, intra-articular inflammation and structural pathology. Here we investigate whether the IPFP is responsive to body weight loss/gain in women and how its responsiveness to weight change compares to that of subcutaneous fat (SCF) of the thigh. All female participants of the Osteoarthritis Initiative (OAI) with ≥10% weight loss/gain between baseline and a 2-year follow-up were included. Within-subject changes in IPFP volume and SCF cross-sectional areas (CSA) were determined from 3-T magnetic resonance imaging. Linear regression was used to assess the association between change in weight, IPFP volume, and SCF CSA. In the 38 participants with ≥10% weight loss over 2 years (age 59.3 ± 9.1 years, mean loss = 15.9%), there was a significant reduction in IPFP volume (-2.2%, p = 0.02) as well as in SCF CSA (-22%, p < 0.001). In the 34 participants with ≥10% gain (age 61.5 ± 8.7 years, mean gain = 15.9%), there was a significant increase in SCF CSA (+26%, p < 0.001) but not in IPFP volume (0.2%, p = 0.87). Weight change was significantly associated with SCF CSA change (r = 0.76, p < 0.001) but not with IPFP volume change (r = 0.11, p = 0.37). In this first longitudinal, observational study investigating the responsiveness of IPFP and SCF to weight change, IPFP morphology was found responsive to weight loss but not to weight gain. Overall, the responsiveness of the IPFP was substantially less than that of the SCF.

scholarly journals Body weight loss and associated factors among adults People living with HIV/AIDS on antiretroviral therapy in Shashemane referral Hospital, Oromia national regional state, Ethiopia: A facility based cross sectional Study

2020 ◽  
Author(s):  
Dedefo Bati Bedassa ◽  
Tsegaye Demissie Gamebo ◽  
Dereje Yohannes Teferi
Keyword(s):  
Weight Loss ◽  
Body Weight ◽  
Body Weight Loss ◽  
Cross Sectional Study ◽  
Referral Hospital ◽  
People Living With Hiv ◽  
Cross Sectional ◽  
Under Nutrition ◽  
Living With Hiv ◽  
Hiv Aids

Abstract Background: HIV/AIDS and under nutrition commonly manifested as body weight loss are both highly prevalent in many parts of the world. Their effects are interrelated and act in a vicious cycle. Both HIV and under nutrition can independently cause progressive damage to the immune system and increased susceptibility to infection. Ethiopia is one of the countries affected by both epidemics, despite, study done on acute under nutrition among HIV/AIDS adults in particular were found inadequate. Thus the main aim of this study is to assess the magnitude of acute under nutrition (weight loss within 3 months) and associated factors among people living with HIV/AIDS adults on ART in Shashemane referral Hospital. Methods: Facility based cross-sectional study conducted in shashemane referral Hospital Oromia region, Ethiopia from August 3 to September 4.2016. Systematic random sampling technique employed and 402 study participants were included. Data was collected by interview patients using pre-tested structured questionnaire, review of patients register, weight and height measurements were taken. The data were entered into Epi Info version 3.5.1 and analyzed using version 20 SPSS statistical package and percentages of body weight loss were calculated. Logistic regression analyses were carried out to identify factors associated with body weight loss of > 5% within three months. Strength of association determined using P< 0.05 and odd ratio (95% CI). Result: The magnitude body weight loss > 5% were 15.9% (95% CI; 12.4-19.7). Low CD4 level of less than 200mm3/ml (AOR=8.41,95% CI:3.46-20.44), inability to consume high protein diets like meat, egg & fish per week (AOR=2.97, 95% CI;1.39-6.35), low meal frequency of 2 or less per day (AOR=3.09,95% CI: 1.25-7.68) and low average income of 1000 birr per month (AOR=9.07,95% CI: 3.71-22.14) were significantly associated with Body weight loss of > 5% within 3 months with P<0.05. Conclusion: Body weight loss >5% within 3 months(acute under nutrition) is still a problem in people living with HIV/AIDS adults on ART, specifically among advanced immune compromised, low income, consumes less meal frequently per day and fewer or no consumption of animal product.

scholarly journals Weight Loss Medications in Young Adults after Bariatric Surgery for Weight Regain or Inadequate Weight Loss: A Multi-Center Study

Children ◽  
2018 ◽  
Vol 5 (9) ◽  
pp. 116 ◽  
Author(s):  
Alexander Toth ◽  
Gricelda Gomez ◽  
Alpana Shukla ◽  
Janey Pratt ◽  
Hellas Cena ◽  
...  
Keyword(s):  
Weight Loss ◽  
Young Adults ◽  
Body Weight ◽  
Weight Change ◽  
Weight Regain ◽  
Body Weight Loss ◽  
Total Body Weight ◽  
Percent Weight Loss ◽  
Total Body ◽  
Weight Loss Medications

This paper presents a retrospective cohort study of weight loss medications in young adults aged 21 to 30 following Roux-en-Y gastric bypass (RYGB) and sleeve gastrectomy (SG) between November 2000 and June 2014. Data were collected from patients who used topiramate, phentermine, and/or metformin postoperatively. Percentage of patients achieving ≥5%, ≥10%, or ≥15% weight loss on medications was determined and percent weight change on each medication was compared to percent weight change of the rest of the cohort. Our results showed that 54.1% of study patients lost ≥5% of their postsurgical weight; 34.3% and 22.9% lost ≥10% and ≥15%, respectively. RYGB had higher median percent weight loss (−8.1%) than SG (−3.3%) (p = 0.0515). No difference was found in median percent weight loss with medications started at weight plateau (−6.0%) versus after weight regain (−5.4%) (p = 0.5304). Patients taking medications at weight loss plateau lost 41.2% of total body weight from before surgery versus 27.1% after weight regain (p = 0.076). Median percent weight change on metformin was −2.9% compared to the rest of the cohort at −7.7% (p = 0.0241). No difference from the rest of the cohort was found for phentermine (p = 0.2018) or topiramate (p = 0.3187). Topiramate, phentermine, and metformin are promising weight loss medications for 21 to 30 year olds. RYGB patients achieve more weight loss on medications but both RYGB and SG benefit. Median total body weight loss from pre-surgical weight may be higher in patients that start medication at postsurgical nadir weight. Participants on metformin lost significantly smaller percentages of weight on medications, which could be the result of underlying medical conditions.

The value of Atriplex (Saltbush) and Kochia (Bluebush) species as food for sheep

1966 ◽  
Vol 17 (2) ◽  
pp. 147 ◽  
Author(s):  
AD Wilson
Keyword(s):  
Weight Loss ◽  
Body Weight ◽  
Fresh Water ◽  
Seasonal Change ◽  
Weight Change ◽  
Dry Matter ◽  
Body Weight Loss ◽  
Dry Matter Intake

Penned sheep were fed on species of Atriplex or Kochia, either alone or as supplements to a roughage diet. The intake and digestibility of the diets, and the weight change of the sheep were recorded. The digestible dry matter intake of A. nummularia and A. vesicaria was sufficient for maintenance of the sheep, provided that fresh water was available. There was little seasonal change in the quality of the Atriglex diets. The intake of a protein-deficient roughage was not altered by the addition of 150 g dry matter of Atriplex or Kochia as a supplement. Body weight loss was decreased or gain increased, but neither significantly, by the addition of these supplements which were high in nitrogen.

Developmental growth and body weight loss of cattle. II. Dissected components of the commercially dressed and jointed carcass

1968 ◽  
Vol 19 (3) ◽  
pp. 477 ◽  
Author(s):  
RM Seebeck ◽  
NM Tulloh
Keyword(s):  
Weight Loss ◽  
Body Weight ◽  
Subcutaneous Fat ◽  
Body Weight Loss ◽  
Rate Of Change ◽  
Carcass Weight ◽  
Unit Weight ◽  
Developmental Growth ◽  
Group A ◽  
Group B

The effects of developmental growth and of body weight loss on the carcass composition of Angus steers, as measured by dissection of butcher's joints, are described. Two groups of steers were used: group A, which grew continuously, and group B, which grew like group A and was then subjected to a period of weight loss before slaughter. Animals in both groups were killed at the same body weights. Statistical analysis consisted of analyses of covariance of weights of components converted to logarithms.The proportions of muscle and bone decreased significantly as carcass weight increased, while the proportions of all fat components (particularly subcutaneous fat and kidney and channel fat) increased. Developmental growth also influenced the distribution of the components in the carcass, particularly muscle, subcutaneous fat, and intermuscular fat. These changes in weight and distribution of components appeared to be detrimental to carcass value per unit weight. During body weight loss, the weights of bone and of connective tissue remained relatively constant, although with bone the rate of change varied significantly with the size of the animal before weight loss. All other components lost weight, approximately reversing the pattern of development during body weight increase (as estimated from the group A animals). The muscle content of the group B animals was, however, significantly lower than in group A animals at the same carcass weight. Kidney and channel fat also tended to be lower in group B than in group A, but this depended on the size of the animal before undergoing body weight loss. When all fat tissues were considered together, group B carcasses were only slightly lower in fat content than group A carcasses at the same carcass weight, and this difference was not statistically significant. Changes in the distribution of dissected components were also shown to occur with body weight loss. The changes in both weight and distribution of the dissected components appeared to be detrimental to carcass value per unit weight.

scholarly journals DNA methylation signature in blood mirrors successful weight-loss during lifestyle interventions: the CENTRAL trial

2020 ◽  
Vol 12 (1) ◽  
Author(s):  
Maria Keller ◽  
Anat Yaskolka Meir ◽  
Stephan H. Bernhart ◽  
Yftach Gepner ◽  
Ilan Shelef ◽  
...  
Keyword(s):  
Physical Activity ◽  
Dna Methylation ◽  
Weight Loss ◽  
Body Weight ◽  
Lifestyle Intervention ◽  
Weight Change ◽  
Relative Weight ◽  
Body Weight Loss ◽  
Obesity Treatment ◽  
Successful Weight Loss

Abstract Background One of the major challenges in obesity treatment is to explain the high variability in the individual’s response to specific dietary and physical activity interventions. With this study, we tested the hypothesis that specific DNA methylation changes reflect individual responsiveness to lifestyle intervention and may serve as epigenetic predictors for a successful weight-loss. Methods We conducted an explorative genome-wide DNA methylation analysis in blood samples from 120 subjects (90% men, mean ± SD age = 49 ± 9 years, body mass-index (BMI) = 30.2 ± 3.3 kg/m2) from the 18-month CENTRAL randomized controlled trial who underwent either Mediterranean/low-carbohydrate or low-fat diet with or without physical activity. Results Analyses comparing male subjects with the most prominent body weight-loss (responders, mean weight change − 16%) vs. non-responders (+ 2.4%) (N = 10 each) revealed significant variation in DNA methylation of several genes including LRRC27, CRISP2, and SLFN12 (all adj. P < 1 × 10−5). Gene ontology analysis indicated that biological processes such as cell adhesion and molecular functions such as calcium ion binding could have an important role in determining the success of interventional therapies in obesity. Epigenome-wide association for relative weight-loss (%) identified 15 CpGs being negatively correlated with weight change after intervention (all combined P < 1 × 10− 4) including new and also known obesity candidates such as NUDT3 and NCOR2. A baseline DNA methylation score better predicted successful weight-loss [area under the curve (AUC) receiver operating characteristic (ROC) = 0.95–1.0] than predictors such as age and BMI (AUC ROC = 0.56). Conclusions Body weight-loss following 18-month lifestyle intervention is associated with specific methylation signatures. Moreover, methylation differences in the identified genes could serve as prognostic biomarkers to predict a successful weight-loss therapy and thus contribute to advances in patient-tailored obesity treatment.

scholarly journals Analysis of factors contributing to postoperative body weight change in patients with gastric cancer: based on generalized estimation equation

PeerJ ◽  
2020 ◽  
Vol 8 ◽  
pp. e9390
Author(s):  
Qiuju Tian ◽  
Liyuan Qin ◽  
Weiyi Zhu ◽  
Shaojie Xiong ◽  
Beiwen Wu
Keyword(s):  
Gastric Cancer ◽  
Weight Loss ◽  
Body Weight ◽  
Cancer Patients ◽  
Total Gastrectomy ◽  
Weight Change ◽  
Body Weight Loss ◽  
Body Weight Change ◽  
Generalized Estimation Equation ◽  
Gastric Cancer Patients

Aims The study aimed to explore factors contributing to body weight change over time in gastric cancer patients after gastrectomy, in order to find risk factors to implement nutritional intervention beforehand. Methods A cohort of gastric cancer patients who were treated with gastrectomy from January to March 2019 at a university affiliated hospital in Shanghai were consecutively identified in this study. Demographics, disease related information, nutrition knowledge, attitude, and practice score were collected before gastrectomy. In addition, body weight before surgery (T0), body weight at one month (T1), two months (T2), and three months (T3) after gastrectomy were recorded. Generalized estimation equation was used to describe body weight change and analyze factors contributing to body weight change after surgery. Results There were 49 patients recruited in the study. Patient body weight decreased by 9.2% at T1 (Wald χ = 271.173, P <0.001), 11.0% at T2 (Wald χ2 = 277.267, P <0.001), and 11.4% at T3 compared to baseline at T0 (Wald χ = 284.076, P <0.001). The results of GEE for multivariable analysis showed that surgery type (Wald χ = 6.027, P = 0.014) and preoperative BMI (Wald χ = 12.662, P = 0.005) were contributing factors of body weight change. Compared with distal gastrectomy patients, total gastrectomy patients experienced greater body weight loss (β = 2.8%, P = 0.014). Compared with patients with BMI&λτ; 18.5 kg/m2, patients with BMI ≥ 25 kg/m2experienced greater body weight loss (β = 4.5% P = 0.026). Conclusion Gastric cancer patients experienced significant weight loss during 3 months after gastrectomy. Total gastrectomy and BMI ≥ 25 kg/m2were risk factors to postoperative body weight loss for GC patients. The results suggested hinted that clinician should pay attention to postoperative nutrition status of patient undergoing total gastrectomy and obesity patients.

The effect of dietary crude protein concentration and time of weaning on milk production and body-weight change in the ewe

1974 ◽  
Vol 19 (3) ◽  
pp. 331-339 ◽  
Author(s):  
J. J. Robinson ◽  
C. Fraser ◽  
J. C. Gill ◽  
I. McHattie
Keyword(s):  
Weight Loss ◽  
Body Weight ◽  
Milk Production ◽  
Weight Change ◽  
Crude Protein ◽  
Body Weight Loss ◽  
Metabolizable Energy ◽  
Body Weight Change ◽  
The Mean ◽  
Incremental Increase

SUMMARYTwenty-seven North Country Cheviot ewes, each carrying twin foetuses and having a mean body weight at 6 weeks prior to parturition of 81 kg were individually penned and offered a constant daily intake of 16·75 MJ metabolizable energy during the last 6 weeks of gestation. At parturition the ewes were allocated to one of three dried grass/concentrate diets containing (1) 10·3, (2) 13·6 or (3) 16·9 % crude protein (CP) and 10 MJ metabolizable energy (ME) per kg. The mean daily CP intakes for diets 1 to 3 were 273, 340 and 415 g respectively and the mean daily ME intake was 25 MJ. Within each level of dietary CP intake the lambs were weaned at either 25, 35 or 41 days of age.There were no significant diet × stage of weaning interactions in milk yield or ewe body-weight change during lactation. The mean daily levels of milk production were 2·4, 2·9 and 3·1 kg for diets 1 to 3 respectively. The corresponding values for ewe body-weight loss were 118, 170 and 265 g per day. When the diet contained 13·8% CP the incremental increase in milk production per unit increase in protein intake was 4·2 g/g. This gave an incremental increase in lamb growth rate of 0·79 g/g and was equivalent to the associated incremental increase in ewe body-weight loss.A reduction in the concentration of CP in the ewes' diet when the lambs are 3 weeks of age may be a useful practical procedure for decreasing milk production and for reducing the body-weight loss of the ewe in a frequent breeding system.

scholarly journals P1080INCREASE OF POST DIALYSIS HEMOGLOBIN CONCENTRATION IS MORE APPROPRIATELY EXPLAINED BY PLASMA VOLUME CHANGE THAN INTRADIALYTIC WEIGH LOST

2020 ◽  
Vol 35 (Supplement_3) ◽  
Author(s):  
Elena Babalj Banskolieva ◽  
Risto Grozdanovski ◽  
Katerina Spaseska Gjurovska ◽  
Marko Ilievski ◽  
Biljana Filipovska ◽  
...  
Keyword(s):  
Weight Loss ◽  
Body Weight ◽  
Plasma Volume ◽  
Volume Change ◽  
Body Weight Loss ◽  
Volume Changes ◽  
Clinical Instability ◽  
Plasma Volume Change ◽  
The Mean ◽  
Group B

Abstract Background and Aims It is well known that haemoglobin significantly increases after haemodialysis and it is associated with the rate of weight loss during dialysis. However, it has been shown that the increase in haemoglobin is not always proportional to the rate of body weight loss during haemodialysis (ultrafiltration). The purpose of the study was to investigate the correlation between haemoglobin changes, body weight loss and plasma volume changes during haemodialysis Method A prospective study was performed on 92 patients in mid-week treatments. Pre-dialysis and post-dialysis haemoglobin and weight were measured. 27 patients were excluded because clinical instability, no change or a decrease in Hb and low pre-dialysis haemoglobin (&lt; 9 g/dL). The correlation was statistically significant between %ΔPV and ΔHb in both groups (R2=0.59), whereas the correlation between %ΔBW and ΔHb was lower (R2=0.19). So, analysis show that only 19% of the variability in haemoglobin is explained by %ΔBW, and that 59% of the variability in haemoglobin is explained by %ΔPV. Results The mean age was 61.16 ± 13.11 year. The men were 52 (56%). The mean pre-dialysis Hb was 11.31 ± 1.16 g/dL, the mean post-dialysis Hb level was 12.53 ± 1.47 g/dL. The mean absolute change of haemoglobin (ΔHb g/dL) and percent of change of haemoglobin (%ΔHb) were 1.22 ± 0.76 and 9.44 ± 5.31, respectively. Average percent of weight change (%ΔBW) was - 2.44 ± 1.01. Percent of plasma volume change was - 9.22 ± 5.46. The patients were divided in two groups according post-dialysis haemoglobin level: Group A with haemoglobin Hb &lt; 13 g/dL (64 patients) and group B with Hb ≥13 g/dL (28 patients). The mean time average haemoglobin concentration (TAC Hb) in all patients was 11.68 ± 1.11 g/dL.(Predicted Hb TAC was calculated according Krisper′s formula) In both groups there was an increase in %ΔHb, but in the group with post dialysis Hb ≥ 13 g/dL, %ΔHb was greater than in group B with post dialysis Hb &lt; 13 g/dL (13.08 ± 5.11 versus 7.87± 4.61, P = 0.000) despite the relatively small difference of %ΔBW between the two groups (- 2.85 ± 0.95 versus - 2.23 ± 1.02; P = 0.010). However, the difference in %ΔPV between the two groups was significant (- 12.90 ± 5.63 versus - 7.61 ± 4.57; P &lt; 0.000). Conclusion The intradialytic changes in haemoglobin levels are predominantly determined by changes in plasma volume. Changes in body weight are of little predictive value in evaluation of variation of haemoglobin levels. TAC Hb determination should be performed in patients with large variations in plasma volume, because the plasma volume has very little effect on TAC Hb.

1965-P: Glucagon Receptor Agonism Stimulates Body Weight Loss in Antibiotic Treatment in Obese Mice

Diabetes ◽  
2019 ◽  
Vol 68 (Supplement 1) ◽  
pp. 1965-P
Author(s):  
TEAYOUN KIM ◽  
JESSICA P. ANTIPENKO ◽  
SHELLY NASON ◽  
NATALIE PRESEDO ◽  
WILLIAM J. VAN DER POL ◽  
...  
Keyword(s):  
Weight Loss ◽  
Body Weight ◽  
Antibiotic Treatment ◽  
Body Weight Loss ◽  
Obese Mice ◽  
Glucagon Receptor
Sign in / Sign up

Export Citation Format

Share Document